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Abstract: 
 
Bacteriorhodopsin (BR) is a membrane protein of known structure. widely used for the 
homology modeling of G-protein-coupled receptors (GPCR). The observation of apparently 
transposed sequence similarities between some of the helical domains of BR and GPCR has led 
to the suggestion that exon shuffling may have occurred in the later evolution of GPCR, which 
would necessitate a different folding pattern for the seven transmembrane helices of GPCR. An 
alternate hypothesis is that duplicat10n occurred in the evolution of an ancestral gene, such that 
helices 5-7 originated as duplicates of helices 1-3, leading to intragenic as well as intergenic 
similarities between helices 1-3 and 5-7 of BR and various GPCR Analyses of GPCR and BR 
sequences suggest that such a duplicat10n may have occurred; symmetry within the BR structure 
is also consistent with homology between these two regions. The hypothesis of evolution by 
duplication is consistent with the conventional, unshuffled homology model, which is also 
supported by the obvious conservation of the retinal binding Lys moiety on helix 7 m both BR 
and the mammalian opsins. 
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Article: 
 
The bacteriorhodopsin (BR) structural prototype [l] has been widely used as a template for the 
homology modeling of membrane proteins in the G-protein-coupled receptor superfamily [2-9], 
however. many investigators engaged in such modeling studies have acknowledged that the 
actual sequence similarity between the transmembrane helical domains of BR and G-protein-
coupled receptors (GPCR) is rather low. Structural similarities have been inferred primarily by 
hydropathy analyses (which consistently predict seven hydrophobic helical domains in GPCR), 
and various lines of biochemical and molecular biological evidence (for recent reviews see [9, 
10]). This low degree of sequence similarity between BR and GPCR is not at all surprising, 
considering that their divergence must have ocurred approximately at the time of that between 
prokaryotes and eukaryotes, which took place at least 1.5 billion years ago [11]. It has been 
noted, however, that for distant homologies, structure is often more highly conserved than 
sequence [12]. 
 
An extremely interesting and provocative result is the recent report by Pardo et al. [13] that the 
greatest sequence similarities between certain individual BR transmembrane helices and the 
predicted GPCR helical regions appear to be out of order. e.g. the seventh BR helix (H7) is most 
homologous to the third GPCR helix (H3). These similarities led Pardo et al. to propose that 
exon shuffling may have occurred in the later evolution of the GPCR. necessitating an alternate 
folding pattern for the seven transmembrane helices of GPCR (Fig. 1). This would also imply 
that the BR structural prototype has been and is being misapplied by virtually all researchers 
working in this area, leading to incorrect models of GPCR and their modes of ligand binding, as 
well as calling into question the basis upon which a great number of molecular biology 
experiments have been designed and interpreted [5,9,10,14.15]. Clearly, then, this is a question 
that must be further investigated and resolved. 
 
 
Fig. 1. Schematic of the 7 helices in the transmembrane domain of BR (BR I–BR VII), showing a hypothetical 
alternate homology to the 7 transmembrane helices of GPCR (Gl–G7), as suggested by Pardo et al. [13]; the 
organization of the seven helices in GPCR is proposed to be somewhat different (compare Fig. 4 of Pardo et al.). 
Note the proposed homology between G1–G3 and BR V–BR VII, which immediately suggests a possible 
duplication of helices 1-3 as helices 5-7. 
 
In this report, we present an alternate and possibly simpler hypothesis to explain the out-of-
sequence helical homologies described by Pardo et al. At least part of their results and suggested 
alternate BR-GPCR homology model (see Fig. 4 in [13]) - specifically, a suggested homology 
between GPCR helices 1-3 and BR helices 5-7 (see Fig. 1) - can immediately be accounted for if 
one postulates that a duplication occurred in the evolution of an ancestral gene, such that helices 
5-7 had originated as duplicates of helices 1-3, or vice-versa (scheme 1). 
 
1–2–3–4 ⇒ 1–2–3–4–5–6–7 
(1–2–3) 
(Scheme 1) 
 
By this interpretation, the apparently anomalous observations of Pardo et al. could be explained 
as having been due to residual sequence similarities between homologous helices within the 
GPCR and BR genes; in this case, one would expect to see some evidence of intragenic as well 
as intergenic similarities between helices 1-3 and 5-7 of BR and various GPCR. 
 
 
Fig. 2. Evidence of helix duplication m BR and GPCR. In these multi-alignments, in addition to identities, the 
following chemically or evolutionarily related residues are shown as matches by bold highlighting: Glu (E) ≡ Gin 
(Q); Asp (D) ≡ Asn (N); Val (V) ≡ Leu (L) ≡ Ile (I); Ser (S) ≡ Thr (T); Ala ≡ Gly (G). Alignments in this and the 
following figures were generated using the GAP program in the UWGCG software package [22]. (A) Intragenic 
homology between Hl and H5 of BR and GPCR is illustrated. In BR, H1 and H5 have 43% identity and 70% 
similarity, with one deletion. In the set of muscarinic sequences shown, aligning from the Glu or Gin at the N-
terminal ends of H1 and H5, conserved residues include a Thr and a hydrophobic cluster ending m Met near the C-
terminal, as well as conserved branched aliphatic amino acids (L, I or V) m several positions. (B) Similarity between 
H2 and H6 is immediately apparent in GPCR, if one aligns the praline (Pl residues(⁎) that are well conserved in each 
of these helices (the Pro in H2 is conserved only in the aromatic monoamine GPCR). For the five adrenergic 
sequences shown, in addition to the similarity around the conserved praline (hPF, h = hydrophobic), at the N-
terminal end of the alignment there is a partially conserved Phe (F), followed by a match between SLA m H2 with 
TLG in H6; mall five of the adrenergic sequences, either LA or LG is found at this point in both H2 and H6. At a 
number of additional positions, branched aliphatic amino acids (L, I or V) are conserved. (C) Similarities between 
GPCR H3 and H7 are illustrated using, β -adrenergic and muscarinic sequences. Alignment of the Ser residues(⁎) 
that are completely conserved in both H3 and H7 of the monoamine GPCR brings the two helices into register; this 
also aligns the well conserved Asp of H3 with the important Asn in H7 of β1 and β2 [21]; the importance of these 
homologous residues is discussed in the text in the context of the BR structure. In addition to a number of branched 
aliphatic amino acids, residues at least partially conserved in both H3 and H7 include a Trp (W) found near the N-
terminal, the Ser, an Asn, and a Phe at the C-terminal end. There is also an obvious similarity between Asp-Arg-
(Tyr)-Phe (which includes the highly conserved DRY sequence) at the end of H3 and Asn-Lys-(Ala)-Phe at the end 
of H7 in the Ml sequence. 
 
Since, like exon shuffling, evolution by duplication and subsequent divergence of duplicated 
domains is a well established evolutionary mechanism, this possibility clearly warrants serious 
investigation. Pairwise comparisons of the sequences of helices 1, 2 and 3 to helices 5, 6 and 7 
(i.e. HI vs. HS, H2 vs. H6 and H3 vs. H7) from various GPCR, as well as BR Hl vs. BR HS, are 
shown in Fig. 2. The sequence similarities shown are between different numbered helices from a 
single gene, or from related sets of genes of monoamine neurotransmitter receptors; the latter 
involve comparisons of regions of multi-alignments for the relevant helical domains of various 
GPCR. Note that in GPCR both H2 and H6 contain a conserved proline, and both H3 and H7 
contain a conserved serine; simply by aligning these highly conserved residues, one can produce 
the alignments shown in Fig. 2 for these pairs of helices. 
 
One of the most striking matches (Fig. 2A) is in BR itself, between Hl and HS, which have an 
impressive 43% identity and 70% similarity, with one deletion*. As the multi-alignments of Fig. 
2 demonstrate, there are distinct similarities between the pairs of helices in the H1-H3 and H5-
H7 segments of GPCR. These are intragenic similarities, suggesting that a duplication may have 
occurred in the evolution of an ancestral gene. Given these apparent similarities, it seems natural 
to ask how well they fit into the context of a larger alignment between the two regions of the 
gene encompassing H1-H3 and H5-H7. The BR gene is most suitable for such a comparison, 
since it lacks the large hydrophilic loop between HS and H6 found in the mammalian GPCR (the 
cytosolic G-protein binding domain), which was probably incorporated in the gene sometime 
after the divergence with the bacterial gene. 
 
As shown in Fig. 3, the BR precursor gene (from which the first 13 residues are proteolytically 
cleaved to form the mature protein) can be divided into two pieces which can be aligned with 
only a few small gaps, in such a way as to bring the helical regions into alignment as expected: 
H1 vs. H5, H2 vs. H6, and H3 vs. H7. In addition to the helical domains being 'in register', there 
is sufficient conservation of sequence that the alignment is statistically significant at the 3 S.D. 
level, relative to the same sequences randomized. This is about as much sequence similarity as 
one could realistically expect to find, considering that if such a duplication did take place in the 
evolution of an ancestor of BR and GPCR, it must have predated the divergence between 
prokaryotes and eukaryotes. It is also noteworthy that the sequence similarities between these 
two halves of the BR gene are fairly evenly distributed throughout the sequence, rather than 
being confined to the helical regions. Not only is this what one would expect based upon a 
uniform mutation rate following a gene duplication: it also suggests that the significance level of 
 
* The significance of this H1-H5 match can be appreciated by comparing it to the match of H1 with the other BR 
helices. Using the GCG GAP program [22] with a gap weight of 4 and gap length weight of 0.5, pairwise alignments 
of H1 with H2, H3, H4, H6 and H7 had only 10-16% identity (average: 14%), with an average quality score of 10.1 
± 1.15. By comparison, the H1-H5 match had 43% identity and a quality score of 14.4. which is 3.7 standard 
deviations above the average score of the matches to the other BR helices. 
the alignment cannot simply be ascribed to inherent similarities between the amphipathic helices 
that typically characterize such membrane proteins. 
 
 
Fig. 3. Intragenic homology (21 % identity, 46% similarity) at the protein sequence level between the N- and C-
terminal portions of the BR precursor gene (residues 1-130 vs. 131-260). Note that the homologous helical pairs Hl-
H5, H2-H6 and H3-H7 are 'in register' with only a few small gaps; the aligned Asp (D) residues m H3-H7 are those 
shown in Fig. 4. bottom panel. which act as counterions in retinal binding: they are at identical depths within the 
lipid bilayer. The alignment shown is a composite of several slightly different alignments produced by the GAP 
program [22], using different gap and length weights. The alignment is statistically significant at > 3.0 S.D. over the 
same alignment randomized. Specifically, with a gap weight of 2.0 and a gap length weight of 0.5. the alignment 
quality score is 52.l; the random quality score of 100 randomized runs is 45.1 ± 2.3, so the actual alignment scored 
3.04 S.D. over random. Also note that the residue numbering scheme for this alignment differs from the 
conventional numbering for the mature BR protein, in which the first 13 residues have been removed m post-
translational processing. 
 
The alignment shown in Fig. 3 could be used to support several possible scenarios for the origin 
of the 7-helix protein. One possibility would be that shown above as Scheme 1 and would 
suggest that H4 was already in place, and that only helices 1-3 were copied and added on to 
create helices 5-7 (or vice versa). The other possibility suggested by Fig. 3 would involve a 
different origin for H4. Since the gene can be divided almost exactly in half, with the 
homologous helical pairs of H1-H3 and H5-H7 in register, the origins of the BR gene from an 
ancestral transmembrane protein or protein module having only three helices is suggested; in this 
case, H4 would have arisen from loop regions forming the connection between the duplicate 
domains (Fig. 4, top panel). This would be a direct consequence of the need to maintain the 
correct transmembrane orientation of the two equivalent 3-helix transmembrane domains (H1-H3 
and H5-H7), which would each have had dipole moments that would dictate the correct out-to-in 
orientation for odd numbered helices [16,17]. The transmembrane potential would have provided 
an electrostatic force, causing the connecting segment to be dragged across the membrane in 
order to maintain the correct dipole orientation of the two 3-helix subunits that had been 
connected (Fig 4, top panel). This second possibility for the evolution of the BR gene by 
duplication is summarized in Scheme 2, where {4} indicates that H4 originated from the 
connected ends of the duplicated region, as described above: 
 
1–2–3 ⇒ 1–2–3–{4}–5–6–7 
(1–2–3) 
(Scheme 2) 
 
There are several factors that tend to support such a hypothesis for the origin of H4. As well as 
the fact that, as required by this hypothesis, H4 (residues 120-140) is almost exactly at the center 
of the 262-residue BR precursor gene, previous investigators have pointed out several unusual 
aspects of H4 in BR [l]. For a helix, it has a very high glycine content (24%). In addition, it has 
no aromatic residues, and the lowest total hydrophobicity of any of the BR transmembrane 
helices. All this is consistent with a possible origin from a loop region. 
 
 
Fig. 4. (Top panel) Schematic diagram showing that if a 3-helix transmembrane module was duplicated and joined 
together, in order to maintain the correct orientation of each module with respect to the transmembrane potential 
[16.17], the connecting segment would have to cross the membrane. This suggests the possibility that helix 4 of BR 
could have originated m this manner, consistent with the duplication suggested by the alignment in Fig. 3. (Bottom 
panel) The actual structure of the transmembrane domain of BR [l], with the 7 helices shown as an α-carbon trace, 
with retinal visible in the cleft. Also depicted are the two equivalent Asp residues on H3 and H7. which serve as 
counterions to the protonated Schiff base covalently linking retinal to Lys-216 (not shown). Intramolecular 
symmetry between Hl-H2-H3 and H5-H6-H7 is apparent, with H4 as an extra helix on one side of the cleft - see text 
for discussion. The residue numbering scheme used in this Fig. follows the conventional numbering for the mature 
BR protein (add 13 to obtain the numbering used in Fig. 3 for the BR precursor sequence), and is the same as that 
used in structure BRDI from the Brookhaven Protein Data Bank, which has been visualized using Sybyl 6.0. Tripos 
Associates, St. Louis. 
 
Both Schemes 1 and 2 would lead to homology between H1-H3 and H5-H7. Regardless of which 
of these two hypothetical schemes may have been involved in the evolution of BR, it is evident 
that the molecular symmetry of the BR structure itself supports the suggested homology between 
H1-H3 and H5-H7, with H4 being the 'odd man out' (Fig. 4, bottom panel). This molecular 
symmetry includes two main features: (i) H1 and H5 are located at the ends of the long axis of 
the cleft formed by the seven transmembrane helices; both these helices are in the plane of the 
conjugated portion of the bound retinal, which is parallel to the long axis (Fig. 4, bottom panel). 
H4 is clearly an 'extra' helix on one side, because (ii) H3 and H7 are symmetrically located on 
either side near the center of the cleft. They each contain an aspartic acid residue (D, aligned in 
Fig. 3) projecting into the central cavity, at the same depth within the membrane, and placed so 
that their carboxylate groups can act as counterions for the protonated Schiff base formed by the 
covalent attachment of retinal to the Lys (K) on H7. This lysine (Lys-216) is located one helical 
turn below Asp-212 on H7 (these residues correspond to K229 and D225 in the numbering 
scheme for the BR precursor gene sequence used in Fig. 3). 
 
Of the large number of sensory and neurotransmitter receptors in the GPCR superfamily, clearly 
the mammalian opsins are the ones that would be expected to be most homologous to BR in 
terms of their overall structural characteristics as well as sequence similarities. They both 
covalently bind retinal, the binding of which has been visualized in the BR electron diffraction 
structure ([l]; also see Fig. 4, bottom panel). This expected similarity presents one of the most 
significant problems for the shuffled homology model proposed by Pardo et al. [13], since multi-
alignments clearly demonstrate that the critical Lys involved in retinal attachment is located on 
H7 in the mammalian opsins, as it is in BR. Thus, there is no reason to expect that in the 
mammalian opsins the structural arrangement of the helices with respect to retinal binding is 
radically different from that observed in BR. This, combined with the fact that multi-alignments 
clearly show that the mammalian opsins have substantial homology with the rest of the GPCR 
superfamily [3, 18-20], suggests that the conventional (unshuffled) model for BR-GPCR 
homology is probably correct. The case for the exon shuffled homology model would be much 
more convincing if the retinal-binding Lys was observed on H3 of the mammalian opsins, since 
that is the helix suggested by Pardo et al. to be most homologous to H7 of BR; however, the 
homologous Lys is clearly observed on H7, in precisely the location predicted by the 
conventional, unshuffled homology model. 
 
It should also be noted that according to the conventional homology model, the counterionic 
Asp-212 on BR H7 (Fig. 4) aligns with an Asn (N) on GPCR H7 that is conserved in the β-
adrenergic and 5-HT1A receptors [3]. This Asn on H7 has been shown to be critically important 
for the binding of certain antagonists [21], as it interacts with the phenoxy oxygen of propranolol 
and related compounds, which is very near to the amino group that is known to bind to the 
conserved Asp on H3. Again, the conventional homology model accounts well for these 
similarities in terms of the three-dimensional BR structure, since the two homologous Asp 
residues on H3 and H7 are very near each to other in BR (Fig. 4, bottom panel). 
 
Nonetheless, the question still remains: even if a common ancestor of the BR and GPCR genes 
had evolved by duplication as we have proposed, why should GPCR H3 appear more similar to 
BR H7 than to BR H3? Much of this question involves the relative degree of sequence similarity, 
and unfortunately Pardo et al. do not give any information on the (unshuffled) alignment of BR 
H3 vs. GPCR H3, etc., which would be of some interest for the sake of comparison. It is 
certainly possible that convergent evolutionary forces might lead to (or at least act to conserve) 
sequence similarities between helical pairs such as H3 and H7, perhaps due to their symmetric 
locations in the proteins, as well as between similarly located helices in BR and GPCR (e.g. H3 
vs. H3). One possible explanation of the superior match of BR H7 to GPCR H3 over that of BR 
H3 to GPCR H3, however, arises from the duplication hypothesis that we have proposed based 
in part upon the alignment of Fig. 3. This alignment suggests that several deletions may have 
occurred in H3 during the later evolution of BR, since the homologous BR H7 apparently still 
aligns with H3 of GPCR fairly well [13]. If GPCR H3 sequences are compared to BR H3, 
maintaining the same pattern of gaps shown for the latter in Fig. 3, a reasonable alignment is 
obtained (Fig. 5A). This could explain the difficulty that previous investigators have had in 
aligning BR H3 to GPCR H3, since such alignments are usually performed with a high gap 
penalty. 
 
 
Fig. 5. (A) Multi-alignment of a set of GPCR helix 3 (H3) sequences with BR H3 and BR H7, maintaining the 
pattern of gaps in BR H3 suggested by the alignment between BR H3 and BR H7 shown in Fig. 3. Matches between 
BR H3 and GPCR H3 are shown in bold and indicated by asterisks at the top of the alignment; matches between BR 
H7 and GPCR H3 are highlighted by underlining. Both BR H3 and and BR H7 have nearly the same number of 
matches with this set of GPCR (8 and 9 identities, respectively). This suggests that part of the reason investigators 
have had difficulty in aligning BR H3 with GPCR H3 is that deletions in H3 may have occured in the later evolution 
of BR, making alignment without gaps (the usual approach) difficult. The alignments m Figs. 2 and 3 suggest that, 
rather than exon shuffling [13], an inherent intragenic similarity between H3 and H7 in both BR and GPCR may 
underlie the sim1lanty between BR H7 and GPCR H3 (B) A moderate degree of similarity is detectable across all 
four odd-numbered helices of BR, m add1t10n to the matches shown previously for H1-H5 and H3-H7 (Fig. 3). 
Identities are shown in bold; an asterisk indicates chemically and evolutionarily similar residues in 3 out of 4 or all 
of the sequences in a given position. In particular, note the similarity in the central region of HI and H7 (SA.VGFG 
with TA.MGLG); BR H1 to GPCR H7 was one of the matches reported by Pardo et al. [13]. 
 
Finally, it is significant that the other apparent homologies actually reported by Pardo et al. (BR 
H3 to GPCR H5, and BR HI to GPCR H7) are also matches between odd numbered helices, 
which could be accounted for by a second hypothetical duplication step, preceeding that 
postulated above for 1-2-3 ⇒ 5-6-7. If the gene had evolved by successive duplications (e.g. 1-2 
⇒ 1-2-3-4 ⇒ 1-2-3-4-5-6-7), there could be a residual general similarity between all odd 
numbered helices ('out-to-in' helices). Although it might seem unlikely that two successive 
duplication steps could have occurred in the evolution of the BR gene, there are at least moderate 
similarities visible across all the odd numbered helices of BR, consistent with such a scenario 
(Fig. 5B). In any case, two duplication steps are no less plausible per se than the two 'shuffles' 
that would be required to produce the alternate GPCR arrangement of the BR helices by exon 
shuffling as proposed by Pardo et al. (Fig. I). Proteins such as triose phosphate isomerase provide 
clear and ample evidence that the successive duplication of domains has been a significant factor 
in protein evolution. 
 
In summary, the results reported here provide an alternate interpretation for the observations of 
Pardo et al., and, combined with the arguments given above, support the conventional homology 
model that has been and is being utilized by a large number of research groups. Our results 
suggest that the reported sequence similarity between BR H7 and GPCR H3, and the proposed 
homology between GPCR helices 1-3 and BR helices 5-7, probably arise from an inherent 
intragenic similarity between the Hl-H3 and H5-H7 regions that is observable in both BR and 
many genes in the GPCR superfamily (Fig. 2). 
 
We would like to emphasize that in all probability, the extreme evolutionary distance of these 
hypothetical events - whether exon shuffling or evolution by duplication - will make it 
impossible to prove either hypothesis simply by the analysis of sequence similarities. Molecular 
symmetry considerations (Fig. 4, bottom panel), however, support the hypothesis of an intragenic 
homology in BR. We have also argued that the obvious conservation of the retinal binding 
moiety, the Lys on H7 in both BR and the mammalian opsins, unambiguously supports the 
conventional homology model, consistent with the hypothesis of evolution by duplication, but 
difficult to explain if exon shuffling had occurred. Unfortunately, there is no accepted method for 
quantitatively assessing the significance of such structural correspondences and weighting them 
along with sequence similarities. 
 
Thus, the alternate possibilities of exon shuffling or gene duplication in the evolution of this 
receptor superfamily must both remain hypotheses. until such time as more detailed information 
on the structure and function of GPCR becomes available. 
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